Drug profile · INN
blinatumomab
BLINCYTO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
blinatumomab (BLINCYTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN blinatumomab
Brand BLINCYTO
Route INJECTION
Formulation INJECTABLE
ATC code L01FX07
Frequently asked questions
What is blinatumomab?
blinatumomab (BLINCYTO) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for blinatumomab?
BLINCYTO is a marketed brand name for blinatumomab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of blinatumomab?
blinatumomab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.